Ads
related to: phases of clinical trials
Search results
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
Morning Times· 2 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 5 days ago(NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing...
North Carolina clinical trial success leads to new breast cancer treatment
WXII-TV Winston-Salem· 1 day agoDonna Huie always heard people describe a cancer diagnosis as a "punch to the gut." An extra...
AusperBio to Present AHB-137 Clinical Data Updates at EASL™ Congress 2024
ThePress.net· 1 day ago– The company to present important new data from two Phase I trials of its leading molecule, AHB-137, aimed at achieving a functional cure for chronic hepatitis ...
...Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating...
WRBL Columbus· 2 days agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of subjects achieved PASI 90 after 16 weeks of& ...
Where Will Amgen Be in 3 Years?
Motley Fool via Yahoo Finance· 7 hours agoAside from its biosimilar medicines, Amgen has 28 programs currently in phase 3 clinical trials. Most of those are investigating whether ...
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga· 25 minutes agoSeltorexant is an investigational first-in-class selective antagonist of the human orexin-2 receptor...
Vitestro’s robotic blood drawing device meets trial endpoints
Clinical Trials Arena via Yahoo Finance· 9 hours agoIt may help ease nursing workload and help alleviate staffing shortages. The trial enrolled 609...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 1 day agoCLEAR-1 is claimed to be the first Phase III trial in the IL-23p19 class to report more than 80% of...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 1 day agoThe trial enrolled 388 patients across 70 sites in nine countries. Patients were randomised 1:1...